The acquisition of GeneSystems, with its patented approach to rapid microbiological detection equipment and disposables, expands Pall’s total fluid management capabilities in the $1 billion biopharmaceuticals process monitoring market.
The acquisition also presents Pall with new opportunities in its environmental, food and beverage and water markets.
Eric Krasnoff, Pall Corporation’s chairman and CEO, said: “Customers seek better tools for rapid testing and process monitoring. GeneSystems expands our ability to provide total fluid management to meet customer’s raw materials, production, testing and environmental requirements. GeneSystems’s unique technologies complement Pall’s markets and global reach.”